← Open Payments lookup

CATHERINE MILLET: Open Payments

NPI 1740678317 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,587 in 84 payments from 16 companies in 2025. Trend: 2023 $2,134 · 2024 $1,824 · 2025 $1,587

Food & beverage: $1,587
CompanyPaymentsAmount
GENZYME CORPORATION11$293
Galderma Laboratories, L.P.14$266
ABBVIE INC.11$186
Organon LLC10$138
SUN PHARMACEUTICAL INDUSTRIES INC.11$135
Novartis Pharmaceuticals Corporation3$82
Arcutis Biotherapeutics, Inc.4$78
Janssen Biotech, Inc.4$75
Lilly USA, LLC4$71
Amgen Inc.3$58

Products named: DUPIXENT, NEMLUVIO, SKYRIZI, VTAMA, Zoryve, TREMFYA, OTEZLA, TALTZ.

Industry payments across TX — which companies pay providers there.